A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo
Journal Article
·
· Sci Transl Med 25 May 2011: Vol. 3, Issue 84, p. 84ra43
OSTI ID:1089727
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1089727
- Report Number(s):
- SLAC-REPRINT-2013-362
- Journal Information:
- Sci Transl Med 25 May 2011: Vol. 3, Issue 84, p. 84ra43, Journal Name: Sci Transl Med 25 May 2011: Vol. 3, Issue 84, p. 84ra43
- Country of Publication:
- United States
- Language:
- English
Similar Records
]Discovery of AM-6494: A Potent and Orally Efficacious [beta]-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2
beta 1 Integrin Inhibitory Antibody Induces Apoptosis of BreastCancer Cells, Inhibits Growth, and Distinguishes Malignant from NormalPhenotype in Three Dimensional Cultures and In vivo
Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation
Journal Article
·
Thu Apr 02 00:00:00 EDT 2020
· J. Med. Chem.
·
OSTI ID:1089727
+11 more
beta 1 Integrin Inhibitory Antibody Induces Apoptosis of BreastCancer Cells, Inhibits Growth, and Distinguishes Malignant from NormalPhenotype in Three Dimensional Cultures and In vivo
Journal Article
·
Thu Dec 01 00:00:00 EST 2005
· Cancer Research
·
OSTI ID:1089727
+4 more
Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation
Journal Article
·
Tue Jun 11 00:00:00 EDT 2013
· J. Med. Chem.
·
OSTI ID:1089727
+24 more